Y-box binding protein 1--a prognostic marker and target in tumour therapy

Eur J Cell Biol. 2014 Jan-Feb;93(1-2):61-70. doi: 10.1016/j.ejcb.2013.11.007. Epub 2013 Dec 27.

Abstract

Y-box binding protein 1 (YB-1) is a multifunctional protein involved in various cellular processes including both transcriptional and translational regulation of target gene expression. Significantly increased YB-1 levels have been reported in a number of human malignancies and shown to be associated with poor prognosis and disease recurrence. Indeed, YB-1 can act as a versatile oncoprotein playing an important role in tumour cell proliferation and progression. Consequently, YB-1 not only proves to be a good prognostic tumour marker, but also may be a promising emerging molecular target for the development of new therapeutical strategies. In this review, we discuss both the role of YB-1 in cancer and specifically in malignant melanoma as well as possible translations into the clinics derived thereof.

Keywords: Angiogenesis; Chemoresistance; DNA repair; Genomic instability; Migration/invasion; Oncogene; Proliferation; Survival; Transcription factor; Translational regulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Cell Nucleus / metabolism
  • Humans
  • Melanoma / diagnosis
  • Melanoma / metabolism
  • Melanoma / pathology
  • Melanoma / therapy
  • Molecular Targeted Therapy
  • Neoplasms / diagnosis*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Prognosis
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy
  • Y-Box-Binding Protein 1 / genetics
  • Y-Box-Binding Protein 1 / metabolism*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Y-Box-Binding Protein 1